“Somatic Mutations of Isocitrate Dehydrogenases 1 and 2 Are Prognostic and Follow-up Markers in Patients With Acute Myeloid Leukemia With Normal Karyotype”. 2016. Radiology and Oncology 50 (4). https://www.radioloncol.com/index.php/ro/article/view/2580.